Legal & General Group’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Legal & General Group’s Portfolio CVRS Stock Details CVRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-15,303	Closed	-$65K	–	3409
2019 Q3	$65K	Hold	15,303	–	–	﹤0.01%	2657
2019 Q2	$46K	Buy	+15,303	New	+$38.3K	﹤0.01%	2814
2018 Q2	–	Sell	-21,513	Closed	-$29K	–	3428
2018 Q1	$29K	Buy	21,513 +7,031	+49%	+$8.16K	﹤0.01%	3003
2017 Q4	$15K	Sell	14,482 -7,377	-34%	-$8.35K	﹤0.01%	3199
2017 Q3	$33K	Buy	21,859 +9,639	+79%	+$16.1K	﹤0.01%	3045
2017 Q2	$23K	Buy	+12,220	New	+$16.3K	﹤0.01%	3139
2017 Q1	–	Sell	-2,908	Closed	-$2K	–	3277
2016 Q4	$2K	Buy	+2,908	New	+$2.45K	﹤0.01%	3283

Legal & General Group's CVRS Position: Q4 2019 in Review

Legal & General Group sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q4 2019, closing a stake of 15,303 shares — an estimated $65K sold.

Legal & General Group first reported a position in CVRS in Q4 2016 and held it in 7 quarters. The position peaked at $65K in Q3 2019. 0 funds tracked by Wall St. Rank hold CVRS as of Q4 2019.

Legal & General Group reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q4 2019 after selling out during the quarter.
Legal & General Group sold 15,303 CORINDUS VASCULAR ROBOTICS, INC shares in Q4 2019, an estimated $65K.
Legal & General Group first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q4 2016 and held it in 7 quarters.
Legal & General Group's CORINDUS VASCULAR ROBOTICS, INC position peaked at $65K in Q3 2019.
0 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q4 2019.

Based on Legal & General Group's 13F filing for Q4 2019, filed 13 Feb 2020.